Differential expression of Type I interferon and inflammatory genes in SARS‐CoV‐2‐infected patients treated with monoclonal antibodies

INTRODUCTION: Considering the reported efficacy of monoclonal antibodies (mAbs) directed against the Spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in reducing disease severity, the aim of this study was to investigate the innate immune response before and after mA...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddaloni, Luca, Santinelli, Letizia, Bugani, Ginevra, Cacciola, Elio G., Lazzaro, Alessandro, Lofaro, Chiara M., Caiazzo, Sara, Frasca, Federica, Fracella, Matteo, Ajassa, Camilla, Leanza, Cristiana, Napoli, Anna, Cinti, Lilia, Gaeta, Aurelia, Antonelli, Guido, Ceccarelli, Giancarlo, Mastroianni, Claudio M., Scagnolari, Carolina, d'Ettorre, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571496/
https://www.ncbi.nlm.nih.gov/pubmed/37904704
http://dx.doi.org/10.1002/iid3.968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571496/
https://www.ncbi.nlm.nih.gov/pubmed/37904704
http://dx.doi.org/10.1002/iid3.968

Ejemplares similares